Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Two percent of patients suspected of having Angelman syndrome have TCF4 mutations
- K. Takano, M. Lyons, C. Moyes, J. Jones, C. Schwartz
- Biology, Medicine
- Clinical genetics
- 1 September 2010
Takano K, Lyons M, Moyes C, Jones J, Schwartz CE. Two percent of patients suspected of having Angelman syndrome have TCF4 mutations.
The New Zealand Hepatitis B Screening Programme: screening coverage and prevalence of chronic hepatitis B infection.
- T. Robinson, C. Bullen, W. Humphries, J. Hornell, C. Moyes
- The New Zealand medical journal
- 11 March 2005
AIM To report on screening coverage and the distribution of HBsAg (a marker of chronic hepatitis B virus infection) among participants in the New Zealand Hepatitis B Screening Programme. METHOD… Expand
Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants
- A. Milne, D. West, D. V. Chinh, C. Moyes, G. Poerschke
- Journal of medical virology
- 1 July 2002
A study involving more than 2,000 infants was conducted in Vietnam to assess the field effectiveness and immunogenicity of recombinant hepatitis B vaccine given at birth, 1 month, 2 months, without… Expand
Genomic Analysis of Hepatitis B Virus Reveals Antigen State and Genotype as Sources of Evolutionary Rate Variation
Hepatitis B virus (HBV) genomes are small, semi-double-stranded DNA circular genomes that contain alternating overlapping reading frames and replicate through an RNA intermediary phase. This complex… Expand
Asthma prevalence in European, Maori, and Pacific children in New Zealand: ISAAC study
The International Study of Asthma and Allergies in Childhood (ISAAC) demonstrated that the highest prevalence of asthma in the world is in English‐speaking countries, including New Zealand. In this… Expand
A seroepidemiological study of the prevalence of hepatitis B infections in a hyperendemic New Zealand community.
- A. Milne, G. Allwood, C. Moyes, N. Pearce, K. Newell
- International journal of epidemiology
- 1 March 1987
The prevalence of hepatitis B surface antigen (HBsAg) and its antibody (anti-HBs) were studied in 93% of the population of the New Zealand township of Kawerau. Sera were collected from 7901 subjects… Expand
HBsAg loss in a New Zealand community study with 28-year follow-up: rates, predictors and long-term outcomes
Background and aimsHBsAg seroclearance is the most desired endpoint in chronic hepatitis B (CHB) but occurs uncommonly. Recent studies have shown baseline HBsAg levels to be predictive of HBsAg loss… Expand
Ethnic differences in time trends in asthma prevalence in New Zealand: ISAAC Phases I and III.
- L. Ellison-Loschmann, P. Pattemore, +8 authors A. Stewart
- The international journal of tuberculosis and…
- 1 June 2009
SETTING The International Study of Asthma and Allergies in Childhood (ISAAC) Phase III survey, New Zealand. OBJECTIVE To assess the prevalence of asthma symptoms and time trends by ethnicity… Expand
Risk factors for asthma symptoms in Kawerau children.
- R. Shaw, K. Woodman, J. Crane, C. Moyes, J. Kennedy, N. Pearce
- The New Zealand medical journal
- 12 October 1994
AIMS To study risk factors for asthma prevalence in Kawerau children aged 8-13 years. METHODS Questionnaires on asthma symptoms and risk factors were completed in 1992 by parents of 708 Kawerau… Expand